Article ; Online: Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients.
Pathology oncology research : POR
2023 Volume 29, Page(s) 1610951
Abstract: Background: ...
Abstract | Background: |
---|---|
MeSH term(s) | Humans ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Immune Checkpoint Inhibitors/adverse effects ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Thyroid Gland/pathology ; B7-H1 Antigen ; Retrospective Studies ; Antineoplastic Agents, Immunological/adverse effects ; Programmed Cell Death 1 Receptor |
Chemical Substances | Immune Checkpoint Inhibitors ; B7-H1 Antigen ; Antineoplastic Agents, Immunological ; Programmed Cell Death 1 Receptor |
Language | English |
Publishing date | 2023-04-17 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 1375979-6 |
ISSN | 1532-2807 ; 1219-4956 |
ISSN (online) | 1532-2807 |
ISSN | 1219-4956 |
DOI | 10.3389/pore.2023.1610951 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4936: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.